主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Entities affiliated with RA Capital | 是 | 227.18万 | 7.40% | 新增 | 新增 | -- |
| 2 | Entities affiliated with New Enterprise Associates | 是 | 223.83万 | 7.30% | 新增 | 新增 | -- |
| 3 | Simeon George | 否 | 223.83万 | 7.30% | 新增 | 新增 | -- |
| 4 | Novo Holdings A/S | 是 | 223.83万 | 7.30% | 新增 | 新增 | -- |
| 5 | Samsara BioCapital, L.P. | 是 | 159.03万 | 5.20% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2026-01-06 | HASTINGS PAUL J |
|
41.61 | 0.00 | 是 | Chief Executive Officer |
| 2026-01-06 | Mahmood Nadir |
|
17.34 | 0.00 | 是 | President |
| 2026-01-06 | Rose Shawn Marshall |
|
7.00 | 0.00 | 是 | Chief Medical Officer, Head of Research & Development |
| 2025-06-18 | HASTINGS PAUL J |
|
32.01 | 1.79 | 是 | Chief Executive Officer |
| 2025-01-15 | Shook David |
|
19.10 | 2.20 | 是 | Chief Medical Officer, Head of Research & Development |
| 2025-01-15 | Levin Alyssa |
|
10.27 | 2.20 | 是 | Chief Financial and Business Officer |
| 2025-01-15 | Brandenberger Ralph |
|
12.48 | 2.20 | 是 | Chief Technical Officer |
| 2025-01-15 | Hager Alicia J. |
|
14.67 | 2.20 | 是 | Chief Legal Officer |
| 2025-01-15 | HASTINGS PAUL J |
|
31.99 | 2.20 | 是 | Chief Executive Officer |
| 2025-01-03 | Levin Alyssa |
|
10.85 | 0.00 | 是 | Chief Financial and Business Officer |
| 2025-01-03 | Hager Alicia J. |
|
15.63 | 0.00 | 是 | Chief Legal Officer |
| 2025-01-03 | Mahmood Nadir |
|
9.34 | 0.00 | 是 | President |
| 2025-01-03 | Brandenberger Ralph |
|
13.22 | 0.00 | 是 | Chief Technical Officer |
| 2025-01-03 | Shook David |
|
19.96 | 0.00 | 是 | Chief Medical Officer, Head of Research & Development |
| 2025-01-03 | HASTINGS PAUL J |
|
33.72 | 0.00 | 是 | Chief Executive Officer |
| 2024-08-21 | Shook David |
|
13.86 | 5.11 | 是 | Chief Medical Officer, Head of Research & Development |
| 2024-07-16 | Hager Alicia J. |
|
10.38 | 8.00 | 是 | Chief Legal Officer |
| 2024-07-15 | Shook David |
|
13.99 | 0.00 | 是 | Chief Medical Officer, Head of Research & Development |
| 2024-06-18 | Trager James |
|
15.10 | 5.60 | 是 | Chief Scientific Officer |
| 2024-06-18 | HASTINGS PAUL J |
|
24.07 | 5.60 | 是 | Chief Executive Officer |
| 2024-06-18 | Hager Alicia J. |
|
10.72 | 5.60 | 是 | Chief Legal Officer |
| 2024-06-18 | Shook David |
|
11.65 | 5.60 | 是 | Chief Medical Officer |
| 2024-06-18 | Brandenberger Ralph |
|
7.97 | 5.60 | 是 | Chief Technical Officer |
| 2024-03-01 | Brandenberger Ralph |
|
8.00 | 12.51 | 是 | Chief Technical Officer |
| 2024-03-01 | Brandenberger Ralph |
|
8.54 | 3.89 | 是 | Chief Technical Officer |
| 2024-03-01 | Brandenberger Ralph |
|
8.83 | 3.89 | 是 | Chief Technical Officer |
| 2024-03-01 | HASTINGS PAUL J |
|
24.05 | 13.33 | 是 | Chief Executive Officer |
| 2024-03-01 | HASTINGS PAUL J |
|
37.81 | 13.00 | 是 | Chief Executive Officer |
| 2024-02-12 | Trager James |
|
14.94 | 12.00 | 是 | Chief Scientific Officer |
| 2024-01-16 | Trager James |
|
15.36 | 8.74 | 是 | Chief Scientific Officer |
| 2024-01-16 | Shook David |
|
11.50 | 8.74 | 是 | Chief Medical Officer |
| 2024-01-16 | HASTINGS PAUL J |
|
39.05 | 8.74 | 是 | Chief Executive Officer |
| 2024-01-16 | Brandenberger Ralph |
|
8.16 | 8.74 | 是 | Chief Technical Officer |
| 2024-01-16 | Hager Alicia J. |
|
10.79 | 8.74 | 是 | Chief Legal Officer |